Vitaflo Scandinavia AB has signed a broadened agreement with Bifodan regarding the Nordic area.

Report this content
(Gothenburg, Sweden, December 22, 2008). Vitaflo Scandinavia AB, a subsidiary of Navamedic, has signed a broadened agreement with Bifodan A/S, Denmark for the product lines of Bifolac® and EcoVag®. Vitaflo has for several years sold Bifolac® and EcoVag® in Denmark and Bifolac® in Sweden and will with this new agreement have the rights to sell both product lines in Sweden, Denmark, Norway, and Finland.




"We are very happy that Bifodan have chosen Vitaflo as their exclusive partner for Bifolac® and EcoVag® in the entire Nordic region. We have successfully marketed their products in Denmark and Sweden for several years, and we are convinced that we can extend this success also to the markets in Norway and Finland", says Tina Madsen, Managing Director in Vitaflo Scandinavia AB.



"Bifodan is looking forward to the extended cooperation with Vitaflo. Bifodan has known Vitaflo as a serious partner for 6 years and trust that Vitaflo will be able to make big success out of marketing Bifolac® and EcoVag® in the whole Nordic region in the coming years", says Ulrik Engelsen, Managing Director of Bifodan A/S.




EcoVag®
EcoVag® is a patented probiotic product within the Female Care area. The product relieves discomfort and restores the intimate natural eco-balance. A recently published double blind, randomised, placebo controlled study shows that EcoVag® significantly reduces the recurrence rate of Bacterial Vaginosis following antibiotic treatment. Bacterial Vaginosis is one of the most frequent vaginal infections and if left untreated may have severe gynaecological and obstetric consequences such as pelvic inflammatory disease, miscarriage and pre-term delivery. Even if Bacterial Vaginosis is successfully cured with commonly used antibiotics, the recurrence rate has been reported as high as 80% after 9 months.




Bifolac®
Bifolac® is a portfolio of probiotic products targeting gastro intestinal health. The products prevent and treat mild diarrhoea and are available in enteric-coated capsules, powder or as a chewable tablet with patent protected microencapsulated bacteria strains.



About Bifodan A/S:
Bifodan has specialized in the development and supply of customized and innovative probiotic solutions for the pharmaceutical and dietary supplement industries. Based on years of specialized experience within formulation and manufacturing of probiotics, Bifodan has introduced a portfolio of unique probiotic concepts, under the EcoVag® and Bifolac® brand names, targeting women's health and gastrointestinal health. Bifodan maintains state of the art manufacturing facilities dedicated to probiotic manufacturing under pharmaceutical GMP conditions.




About Vitaflo:
Vitaflo Scandinavia AB is one of the fastest growing specialty pharmaceutical sales and marketing companies in the Nordic area working in 10 therapy areas. Vitaflo promotes branded and generic prescription medicines, food for specific medical needs as well as OTC-products. Vitaflo has its own marketing presence in Denmark, Finland, Island, Sweden, Norway and Holland and will have market its products through distributors in another 10 territories during 2009.




For further information, please contact:
Roland Sandström, Executive Chairman, Vitaflo Scandinavia AB
E-mail: roland.sandstrom@vitaflo.net
Office: +46 31 335 11 90



Tina Madsen, Managing Director in Vitaflo Scandinavia AB
E-mail: tina.sandstrom@vitaflo.net
Office: +45 48 22 1838



Ulrik Engelsen, Managing Director Bifodan A/S
E-mail: ule@bifodan.com
Office: +45 47 98 15 16

Bernt-Olav Røttingsnes, CFO/IRO Navamedic ASA
E-mail: bor@navamedic.com
Office: +47 67 11 25 44
Mobile: +47 91 34 70 21








Subscribe